Revumenib (Revumenib) genuine original drug price list in 2025

Revumenib (trade name Revuforj®) was developed by Syndax Pharmaceuticals and is the world's first Menin inhibitor approved for the treatment of KMT2A rearranged acute leukemia. The drug has been officially launched in the United States at the end of 2024 for the treatment of children and adults with KMT2A-positive relapsed or refractory acute leukemia. According to public information, the official wholesale purchase price of Revumenib (WAC) is per box19,750USD, available in 110mg or 160mg tablets. Converted according to the current exchange rate, it is approximately RMB 130,000 to RMB 140,000 per box, making it one of the more expensive targeted drugs of this type.

According to the treatment plan, Revumenib needs to be taken orally twice daily. The specific dosage is determined by the patient's weight, age and condition. The general recommended treatment cycle is 28 days, and it may take several months to achieve sustained effects. Market data shows that the average monthly medication cost for an adult patient is approximately US$39,500, or approximately RMB270,000. This price includes multiple boxes of pills and ongoing medication costs, which is a significant expense, especially for leukemia patients undergoing long-term treatment. The financial pressure cannot be ignored.

As of2025, Revumenib has not been approved for marketing by the drug regulatory authorities in China, and domestic pharmacies or hospitals are temporarily unable to provide the drug. For patients who meet the indications and need to use the drug, they must obtain it through overseas medical channels, which usually include going to the United States for medical treatment, ordering through overseas pharmacies, or obtaining prescriptions through regular third-party international medical service agencies and ordering genuine original drugs by mail. This process requires professional medical evaluation, legal channel authorization and prescription documents. Some processes may involve translation, notarization and other services, and the cycle is relatively long.

Reference materials:https://www.drugs.com/